For those on L-DOPA

[Tripple]

newatlas.com/disease/parkin...

[park_bear]

Summary: in a phase II clinical trial a drug under development showed efficacy for relieving levodopa induced dyskinesia. A phase 3 trial and FDA approval decision must still be done, which can be expected to take several years.

[Gcf51 in reply to park_bear]

What I am reading indicates the schizophrenia drug was tested in 2020, I wonder if it will be approved and therefore might be prescribed off label.

[park_bear in reply to Gcf51]

Apparently it passed a phase II trial for schizophrenia in 2020, but likewise would need to pass a phase III trial and approval to be available to patients. celonpharma.com/en/pipeline/

[Dolphinfan]

Sounds promising. Hopefully the FDA won't drag their feet on it.